Beijing Aier-Intech Eye Hospital — Beijing, Beijing Municipality

Public research footprint of Beijing Aier-Intech Eye Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Neovascular Age-Related Macular Degeneration (nAMD) · Wet Age-related Macular Degeneration (wAMD) · Diabetic Macular Edema · Macular Edema Secondary to Retinal Vein Occlusion

Recently updated registry entries

NCT07317934 — Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related… (Recruiting)
NCT07679685 — Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display… (Not Yet Recruiting)
NCT05850520 — A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Beijing Aier-Intech Eye Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.